vimarsana.com
Home
Live Updates
Agilent Technologies : Resolution ctDx FIRST Receives FDA Ap
Agilent Technologies : Resolution ctDx FIRST Receives FDA Ap
Agilent Technologies : Resolution ctDx FIRST Receives FDA Approval as a Liquid Biopsy Companion Diagnostic Test for Advanced Non-small Cell Lung Cancer
Agilent Technologies Inc. announced today that the U.S. Food and Drug Administration has approved Agilent Resolution ctDx FIRST as a companion diagnostic to identify advanced... | December 12, 2022
Related Keywords
United States ,
American ,
Alan Sandler ,
Kenna Anderes ,
Sam Raha ,
Dacosta Byfield ,
Agilent Technologies Inc ,
Genomics Group ,
Cancer Center ,
Drug Administration ,
American Cancer Society ,
Agilent Technologies ,
Agilent Resolution ,
Vice President ,
Translational Medicine ,
Chief Medical ,
Key Statistics ,
American Cancer ,
About Lung Cancer Web ,
Retrospective Analysis ,
Lung Cancer ,
Clinicoecon Outcomes ,
Somatic Mutations ,
Patient Reported Preferences ,
Liquid Biopsies ,
Blood Biomarkers ,
Comprehensive Cancer ,
Cancer Manag Res ,
Prospective Study ,
Circulating Tumor ,
Guide Matched Targeted Therapy ,
Nc Stock Exchange ,
News ,
Information ,
Press Release ,
Agilent ,
Technologies ,
Nnounced ,
Oday ,
Hat ,
The ,
Wood ,
End ,
Drug ,
Administration ,
Gas ,
Approved ,
Resolution ,
Ltdx ,
First ,
Us ,
Companion ,
Iagnostic ,
O ,
Dentifya Us00846u1016 ,